Honey Dressing - A Preventive Procedure for Post-Surgical Site Infection.

Honey Dressing - A Preventive Procedure for Post-Surgical Site Infection

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06220344

Enrollment

Registered

2024-01-23

Start date

2022-12-02

Completion date

2023-03-03

Last updated

2024-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Bleeding, Wound Dehiscence, Wound Infection, Wound Surgical

Brief summary

The goal of this clinical trial is to compare the wound healing in the participants who underwent the clean surgical procedure, by applying honey dressing and common Iodine solution dressing, participants will have no other co-morbidities like Diabetes, Anemia, etc. which can make the results biased. The main questions it aims to answer are: * Do the iodine solutions are enough to counter the infections caused by resistant strains of bacteria? * What is the efficacy and efficiency of honey dressing in wound care? Participants will be tasked to * Ensure strict follow-up in the hospital dressing room * Half of the participants will apply common iodine solution dressing and the other half will be applied honey dressing. Researchers will compare Iodine dressing (Control group) with Honey dressing (Experimental group) to see if Honey dressing is better in the prevention of post-surgery wound infection and if it is cost-efficient and its efficacy.

Interventions

BIOLOGICALHoney Dressing

Honey Dressing will be applied from the 1st Post-Op day till the fully healed wound, which is described as no dehiscence, no exudate, no warmth, and sutures removed.

DRUGIodine Dressing

Iodine Dressing will be applied from the 1st Post-Op day till the fully healed wound, which is described as no dehiscence, no exudate, no warmth, and sutures removed.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

12 Years to 50 Years

Healthy volunteers

Inclusion criteria

Patients with sterile/clean post-surgical wounds are admitted in general surgery, neurosurgery, orthopedic, and gynecology wards and require follow-up dressings.

Exclusion criteria

1. Patients with: * Anemia * BMI\>30 * Local Infection in wound area. * Venous leg ulcers * Diabetes * Immunocompromised (Oncological patients) 2. Patient under negative pressure therapy

Design outcomes

Primary

Measure	Time frame	Description
Signs of Wound Infection	3rd day, 7th day, 15th day.	Presence of exudate, warmth, pus, erythema, dehiscence, contact bleeding, and any systemic sign like fever, rash, and myalgia.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026